What else you should know You may have to stay on Zepbound for life for weight management
A Phase 1 study, with recruitment complete and results expected by the end of 2026, aims to identify a dose with pharmacodynamics at least comparable to the 3HP regimen (three months of weekly isoniazid plus rifapentine)
Giordano, S
Review Article Abstract Introduction Retatrutide for Treatment of Obesity Retatrutide for Treatment of Type 2 Diabetes Effects of Retatrutide on Cardiovascular Risk Factors Safety of Retatrutide Effect of Retatrutide on Heart Rate Advantages of Retatrutide Limitations of Retatrutide Conclusions and Current Needs References References Coskun T, Urva S, Roell WC, Qu H, Loghin C, et al
Some patients may have nausea, vomiting, diarrhea, constipation, stomach discomfort, appetite changes, or dehydration risk
Five additional peptides go to a later PCAC meeting before the end of February 2027